Analysed HEARTSCIENCES INC (HSCS:NASDAQ) News Sources
HeartSciences’ MyoVista Insights™ Receives Epic Toolbox Designation for ECG Management System Category
25-03-2026
yahoo.com
HeartSciences to Present at Investor Summit Group Virtual Conference and Host Virtual One on One Investor Meetings
24-03-2026
yahoo.com
Investor Summit Announces Q1 Presenter Line Up (Presentations 3/25, 1-on-1s 3/26)
20-03-2026
yahoo.com
HeartSciences Reports Fiscal Third Quarter 2026 Financial Results and Provides Business Update
16-03-2026
yahoo.com
University of West England Adopts HeartSciences’ MyoVista Insights™ Platform and MyoVista® wavECG™ Device to Establish ECG Education and Technology Reference Center
05-02-2026
yahoo.com
Cibolo Health Designates HeartSciences’ MyoVista Insights™ as Endorsed ECG Management Platform for Network of 123 Independent Hospitals
29-01-2026
yahoo.com
HeartSciences Reports Fiscal Second Quarter 2026 Financial Results and Provides Business Update
15-12-2025
yahoo.com
HeartSciences Announces Major Upgrade to User Features of MyoVista Insights Platform with Commercial Launch Version 1.1
11-12-2025
yahoo.com
What is the current price of HEARTSCIENCES INC (HSCS:NASDAQ)?
The current price of HEARTSCIENCES INC (HSCS:NASDAQ) is $2.09.
HEARTSCIENCES INC (HSCS:NASDAQ) absolute price change since previous trading day?
The absolute price change of HEARTSCIENCES INC (HSCS:NASDAQ) since the previous trading day is $-0.07.
HEARTSCIENCES INC (HSCS:NASDAQ) percentage price change since previous trading day?
The percentage price change of HEARTSCIENCES INC (HSCS:NASDAQ) since the previous trading day is -3.2407%.
What is the most recent average sentiment score for HEARTSCIENCES INC (HSCS:NASDAQ)?
The most recent average sentiment score for HEARTSCIENCES INC (HSCS:NASDAQ) is 78 out of 100.
What is the most recent average sentiment for HEARTSCIENCES INC (HSCS:NASDAQ)?
The most recent sentiment for HEARTSCIENCES INC (HSCS:NASDAQ) is .
SEC-8K** Filing Available For HEARTSCIENCES INC (HSCS:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.